Happy to be proven wrong put I didn't hear him say they wouldn't need to undertake P2 trials in future. I understood him to say that future P2 trials could be simplified and speeded up by removing some of the current safety protocols if the FDA accepted that the molecule was safe.
- Forums
- ASX - By Stock
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.54%
!
$12.92

Happy to be proven wrong put I didn't hear him say they wouldn't...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.92 |
Change
0.070(0.54%) |
Mkt cap ! $1.607B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.85 | $8.049M | 616.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4175 | $12.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.03 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4175 | 12.910 |
4 | 4488 | 12.900 |
2 | 1762 | 12.890 |
2 | 3348 | 12.880 |
1 | 1508 | 12.850 |
Price($) | Vol. | No. |
---|---|---|
13.030 | 100 | 1 |
13.040 | 6060 | 2 |
13.050 | 1508 | 1 |
13.060 | 7205 | 8 |
13.080 | 1508 | 1 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online